SEARCH

SEARCH BY CITATION

References

  • (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. The New England Journal of Medicine 329, 977986.
  • Abdull MM, Sivasubramaniam S, Murthy GV et al. (2009) Causes of blindness and visual impairment in Nigeria: the Nigeria national blindness and visual impairment survey. Investigative Ophthalmology & Visual Science 50, 41144120.
  • Adegbehingbe BO, Fajemilehin BR, Ojofeitimi EO & Bisiriyu LA (2006) Blindness and visual impairment among the elderly in Ife-Ijesha zone of Osun State, Nigeria. Indian Journal of Ophthalmology 54, 5962.
  • Arnarsson A, Sverrisson T, Stefansson E et al. (2006) Risk factors for five-year incident age-related macular degeneration: the Reykjavik Eye Study. American Journal of Ophthalmology 142, 419428.
  • Bastawrous A & Hennig BD (2012) The global inverse care law: a distorted map of blindness. The British Journal of Ophthalmology 96, 13571358.
  • Bengtsson B (1991) Glaucoma case detection. Acta Ophthalmologica 69, 288292.
  • Berhane Y, Worku A, Bejiga A et al. (2007) Prevalence and causes of blindness and Low Vision in Ethiopia. Ethiopian Journal of Health Development 21, 204210.
  • Boutayeb A (2006) The double burden of communicable and non-communicable diseases in developing countries. Transactions of the Royal Society of Tropical Medicine and Hygiene 100, 191199.
  • Bowler GS, Fayers T & Gouws P (2012) 5.7 Times more expensive than liquid gold. The British Journal of Ophthalmology 96, 1046.
  • Buch H (2005) Fourteen-year incidence of age-related maculopathy and cause-specific prevalence of visual impairment and blindness in a Caucasian population: the Copenhagen City Eye Study. Acta Ophthalmologica Scandinavica 83, 400401.
  • Buch H, Vinding T, la Cour M et al. (2005) Risk factors for age-related maculopathy in a 14-year follow-up study: the Copenhagen City Eye Study. Acta Ophthalmologica Scandinavica 83, 409418.
  • Budenz DL, Bandi JR, Barton K et al. (2012) Blindness and visual impairment in an urban west african population: the tema eye survey. Ophthalmology 119, 17441753.
  • Buhrmann RR, Quigley HA, Barron Y et al. (2000) Prevalence of glaucoma in a rural East African population. Investigative Ophthalmology & Visual Science 41, 4048.
  • Burgess PI, MacCormick IJ, Harding SP et al. (2013) Epidemiology of diabetic retinopathy and maculopathy in Africa: a systematic review. Diabetic Medicine 30, 399412.
  • Cedrone C, Mancino R, Ricci F et al. (2012) The 12-year incidence of glaucoma and glaucoma-related visual field loss in Italy: the Ponza eye study. Journal of Glaucoma 21, 16.
  • Chandrasekaran S, Cumming RG, Rochtchina E & Mitchell P (2006) Associations between elevated intraocular pressure and glaucoma, use of glaucoma medications, and 5-year incident cataract: the Blue Mountains Eye Study. Ophthalmology 113, 417424.
  • Chen SJ, Cheng CY, Peng KL et al. (2008) Prevalence and associated risk factors of age-related macular degeneration in an elderly Chinese population in Taiwan: the Shihpai Eye Study. Investigative Ophthalmology & Visual Science 49, 31263133.
  • Chiang PP, Keeffe JE, Le Mesurier RT & Taylor HR (2006) Global burden of disease and visual impairment. Lancet 368, 365.
  • Choudhury F, Varma R, McKean-Cowdin R et al. (2011) Risk factors for four-year incidence and progression of age-related macular degeneration: the los angeles latino eye study. American Journal of Ophthalmology 152, 385395.
  • Cook C (2009) Glaucoma in Africa: size of the problem and possible solutions. Journal of Glaucoma 18, 124128.
  • Cruickshanks KJ, Klein R, Klein BE & Nondahl DM (2001) Sunlight and the 5-year incidence of early age-related maculopathy: the beaver dam eye study. Archives of Ophthalmology 119, 246250.
  • DF (2009) Diabetes Atlas. 4th edn, International Diabetes Federation, Brussels.
  • Dimitrov PN, Mukesh BN, McCarty CA & Taylor HR (2003) Five-year incidence of bilateral cause-specific visual impairment in the Melbourne Visual Impairment Project. Investigative Ophthalmology & Visual Science 44, 50755081.
  • Dineen B, Foster A & Faal H (2006) A proposed rapid methodology to assess the prevalence and causes of blindness and visual impairment. Ophthalmic Epidemiology 13, 3134.
  • Dineen B, Gilbert CE, Rabiu M et al. (2008) The Nigerian national blindness and visual impairment survey: rationale, objectives and detailed methodology. BMC Ophthalmology 8, 17.
  • Distiller LA, Brown MA, Joffe BI & Kramer BD (2010) Striving for the impossible dream: a community-based multi-practice collaborative model of diabetes management. Diabetic Medicine: A Journal of the British Diabetic Association 27, 197202.
  • Dowse GK, Humphrey AR, Collins VR et al. (1998) Prevalence and risk factors for diabetic retinopathy in the multiethnic population of Mauritius. American Journal of Epidemiology 147, 448457.
  • Evans JR (2006) Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration. Cochrane Database of Systematic Reviews CD000254.
  • Evans JR & Lawrenson JG (2012) Antioxidant vitamin and mineral supplements for preventing age-related macular degeneration. Cochrane Database of Systematic Reviews 6, CD000253.
  • Foster PJ, Buhrmann R, Quigley HA & Johnson GJ (2002) The definition and classification of glaucoma in prevalence surveys. The British Journal of Ophthalmology 86, 238242.
  • Gill GV, Huddle KR & Krige LP (1984) Intensive health screening of young black diabetics. South African medical journal =. Suid-Afrikaanse Tydskrif vir Geneeskunde 65, 815816.
  • Gill GV, Huddle KR & Rolfe M (1995) Mortality and outcome of insulin-dependent diabetes in Soweto, South Africa. Diabetic Medicine: A Journal of the British Diabetic Association 12, 546550.
  • Gill GV, Huddle KR & Monkoe G (2005) Long-term (20 years) outcome and mortality of Type 1 diabetic patients in Soweto, South Africa. Diabetic Medicine: A Journal of the British Diabetic Association 22, 16421646.
  • Glover SJBP, Cohen DB, Harding SP, Hofland HWC, Zijlstra EE & Allain TJ (2012) Prevalence of diabetic retinopathy, cataract and visual impairment in diabetic patients in Sub-Saharan Africa. British Journal Ophthalmology 96, 156161.
  • Guzek JP, Anyomi FK, Fiadoyor S & Nyonator F (2005) Prevalence of blindness in people over 40 years in the volta region of ghana. Ghana Medical Journal 39, 5562.
  • Habiyakire C, Kabona G, Courtright P & Lewallen S (2010) Rapid assessment of avoidable blindness and cataract surgical services in kilimanjaro region, Tanzania. Ophthalmic Epidemiology 17, 9094.
  • Heijl A, Leske MC, Bengtsson B et al. (2002) Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Archives of Ophthalmology 120, 12681279.
  • Herman WH, Aubert RE, Engelgau MM et al. (1998) Diabetes mellitus in Egypt: glycaemic control and microvascular and neuropathic complications. Diabetic Medicine: A Journal of the British Diabetic Association 15, 10451051.
  • Kalk WJJJ, Ntsepo S, Mahomed I, Mahanlal P & Becker PJ (1997) Ethnic differences in the clinical and laboratory associations with retinopathy in adult onset diabetes: studies in patients of African, European and Indian origins. Journal of Internal Medicine 241, 3137.
  • Kalua K, Lindfield R, Mtupanyama M et al. (2011) Findings from a rapid assessment of avoidable blindness (RAAB) in Southern Malawi. PLoS ONE 6, e19226.
  • Kandeke L, Mathenge W, Giramahoro C et al. (2012) Rapid Assessment of Avoidable Blindness in Two Northern Provinces of Burundi without Eye Services. Ophthalmic Epidemiology 19, 211215.
  • Kanski JJ (2007) Clinical Ophthalmology: A Systematic Approach. Elsevier, Amsterdam.
  • Kikira S (2007) RAAB survey of Pemba and Unguja islands, Zanzibar. Community eye Health/International Centre for Eye Health 20, 71.
  • King H AR & Herman WH (1998) Global burden of diabetes, 1995–2025: prevalence, numerical estimates, and projections. Diabetes Care 21, 14141431.
  • Kyari F, Abdull MM, Bastawrous A et al. (2013) Epidemiology of glaucoma in sub-saharan Africa: prevalence, incidence and risk factors. Middle East African Journal of Ophthalmology 20, 111125.
  • Leske MC, Connell AM, Schachat AP & Hyman L (1994) The Barbados eye study. Prevalence of open angle glaucoma. Archives of Ophthalmology 112, 821829.
  • Leske MC, Connell AM, Wu SY et al. (2001) Incidence of open-angle glaucoma: the Barbados Eye Studies. The Barbados Eye Studies Group. Archives of Ophthalmology 119, 8995.
  • Leske MC, Wu SY, Hyman L et al. (2004) Four-year incidence of macular changes in the Barbados Eye Studies. Ophthalmology 111, 706711.
  • Leske MC, Wu SY, Hennis A et al. (2006) Nine-year incidence of age-related macular degeneration in the Barbados Eye Studies. Ophthalmology 113, 2935.
  • Leske MC, Wu SY, Honkanen R et al. (2007) Nine-year incidence of open-angle glaucoma in the Barbados Eye Studies. Ophthalmology 114, 10581064.
  • Lopez AD, Mathers CD, Ezzati M et al. (2006) Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 367, 17471757.
  • Mash BPD, du Plessis F, van Vuuren U, Michalowska M & Levitt N (2007) Screening for diabetic retinopathy in primary care with a mobile fundal camera–evaluation of a South African pilot project. South African Medical Journal 97, 12841288.
  • Mason RP, Kosoko O, Wilson MR et al. (1989) National survey of the prevalence and risk factors of glaucoma in St. Lucia, West Indies. Part I. Prevalence findings. Ophthalmology 96, 13631368.
  • Mathenge W, Kuper H, Limburg H et al. (2007a) Rapid assessment of avoidable blindness in Nakuru district, Kenya. Ophthalmology 114, 599605.
  • Mathenge W, Nkurikiye J, Limburg H & Kuper H (2007b) Rapid assessment of avoidable blindness in Western Rwanda: blindness in a postconflict setting. PLoS Medicine 4, e217.
  • Mathenge W, Bastawrous A, Foster A & Kuper H (2012) The Nakuru Posterior Segment Eye Disease Study: Methods and Prevalence of Blindness and Visual Impairment in Nakuru, Kenya. Ophthalmology 119, 20332039.
  • Mathenge W, Bastawrous A, Peto T et al. (2013) Prevalence of age-related macular degeneration in Nakuru, Kenya: a cross-sectional population-based study. PLoS Medicine 10, e1001393.
  • Mathers CD & Loncar D (2006) Projections of global mortality and burden of disease from 2002 to 2030. PLoS Medicine 3, e442.
  • Mbulaiteye SM, Reeves BC, Karabalinde A et al. (2002) Evaluation of E-optotypes as a screening test and the prevalence and causes of visual loss in a rural population in SW Uganda. Ophthalmic Epidemiology 9, 251262.
  • Mbulaiteye SM, Reeves BC, Mulwanyi F et al. (2003) Incidence of visual loss in rural southwest Uganda. The British Journal of Ophthalmology 87, 829833.
  • Moser CL, Martin-Baranera M, Vega F et al. (2002) Survey of blindness and visual impairment in Bioko, Equatorial Guinea. The British Journal of Ophthalmology 86, 257260.
  • Muller A, Zerom M, Limburg H et al. (2011) Results of a rapid assessment of avoidable blindness (RAAB) in Eritrea. Ophthalmic Epidemiology 18, 103108.
  • Munoz B, Klein R, Rodriguez J et al. (2005) Prevalence of age-related macular degeneration in a population-based sample of Hispanic people in Arizona: Proyecto VER. Archives of Ophthalmology 123, 15751580.
  • Ngondi J, Ole-Sempele F, Onsarigo A et al. (2006) Prevalence and causes of blindness and low vision in southern Sudan. PLoS Medicine 3, e477.
  • Ntim-Amponsah CT, Amoaku WM, Ofosu-Amaah S et al. (2004) Prevalence of glaucoma in an African population. Eye 18, 491497.
  • Oye JE & Kuper H (2007) Prevalence and causes of blindness and visual impairment in Limbe urban area, South West Province, Cameroon. The British Journal of Ophthalmology 91, 14351439.
  • Oye JE, Kuper H, Dineen B et al. (2006) Prevalence and causes of blindness and visual impairment in Muyuka: a rural health district in South West Province, Cameroon. The British Journal of Ophthalmology 90, 538542.
  • Pascolini D & Mariotti SP (2012) Global estimates of visual impairment: 2010. The British Journal of Ophthalmology 96, 614618.
  • Quigley HA & Broman AT (2006) The number of people with glaucoma worldwide in 2010 and 2020. The British Journal of Ophthalmology 90, 262267.
  • Quigley HA, Buhrmann RR, West SK et al. (2000) Long term results of glaucoma surgery among participants in an east African population survey. The British Journal of Ophthalmology 84, 860864.
  • Rabiu MM (2008) Prevalence of blindness and low vision in north central, Nigeria. West African Journal of Medicine 27, 238244.
  • Rabiu MM & Muhammed N (2008) Rapid assessment of cataract surgical services in Birnin-Kebbi local government area of Kebbi State, Nigeria. Ophthalmic Epidemiology 15, 359365.
  • Resnikoff S, Felch W, Gauthier TM & Spivey B (2012) The number of ophthalmologists in practice and training worldwide: a growing gap despite more than 200 000 practitioners. The British Journal of Ophthalmology 96, 783787.
  • Rotchford APRK (2002) Diabetes in rural South Africa–an assessment of care and complications. South African Medical Journal 92, 536541.
  • Rotchford AP & Johnson GJ (2002) Glaucoma in Zulus: a population-based cross-sectional survey in a rural district in South Africa. Archives of Ophthalmology 120, 471478.
  • Rotchford AP, Kirwan JF, Muller MA et al. (2003) Temba glaucoma study: a population-based cross-sectional survey in urban South Africa. Ophthalmology 110, 376382.
  • Rotimi C, Daniel H, Zhou J et al. (2003) Prevalence and determinants of diabetic retinopathy and cataracts in West African type 2 diabetes patients. Ethnicity and Disease 13, S110S117.
  • Salmon JF & Martell R (1994) The role of ethnicity in primary angle-closure glaucoma. South African Medical Journal=Suid-Afrikaanse Tydskrif vir Geneeskunde 84, 623626.
  • Sommer A, Tielsch JM, Katz J et al. (1991) Racial differences in the cause-specific prevalence of blindness in east Baltimore. The New England Journal of Medicine 325, 14121417.
  • Tapp RJ, Zimmet PZ, Harper CA et al. (2006) Six year incidence and progression of diabetic retinopathy: results from the Mauritius diabetes complication study. Diabetes Research and Clinical Practice 73, 298303.
  • Tielsch JM, Katz J, Singh K et al. (1991a) A population-based evaluation of glaucoma screening: the Baltimore Eye Survey. American Journal of Epidemiology 134, 11021110.
  • Tielsch JM, Sommer A, Katz J et al. (1991b) Racial variations in the prevalence of primary open-angle glaucoma. The Baltimore Eye Survey. JAMA: The Journal of the American Medical Association 266, 369374.
  • Varma R, Foong AW, Lai MY et al. (2010) Four-year incidence and progression of age-related macular degeneration: the Los Angeles Latino Eye Study. American Journal of Ophthalmology 149, 741751.
  • Vingerling JR, Hofman A, Grobbee DE & de Jong PT (1996) Age-related macular degeneration and smoking. The Rotterdam Study. Archives of Ophthalmology 114, 11931196.
  • de Voogd S, Ikram MK, Wolfs RC et al. (2005) Incidence of open-angle glaucoma in a general elderly population: the Rotterdam Study. Ophthalmology 112, 14871493.
  • WHO/ICD-10 (2007) Classification of Visual Impairment and Blindness. World Health Organization, WHO Press, Geneva.
  • Williams R, Airey M, Baxter H et al. (2004) Epidemiology of diabetic retinopathy and macular oedema: a systematic review. Eye 18, 963983.
  • World Health Organization (1988) Coding instructions for the WHO/PBL Eye Examination Record (version III). Vol. 88.1, WHO Press, Geneva.
  • Yasuda M, Kiyohara Y, Hata Y et al. (2009) Nine-year incidence and risk factors for age-related macular degeneration in a defined Japanese population the Hisayama study. Ophthalmology 116, 21352140.